《指引》从两方面规范广告内容。在正确导向方面，要求广告需以健康形式表达内容，符合社会主义精 神文明建设和弘扬中华优秀传统文化的要求，坚决杜绝低俗媚俗、制造"容貌焦虑"等内容。事实依据方 面，要求涉及功效宣传需与产品注册、备案资料相符合，如"温和无刺激"等应具备功效宣称的评价试验 证明；使用数据等引证内容的，应标明出处，确保内容真实可溯。 制定17项"负面清单"。其中，明确列出6项禁止发布化妆品广告的情形，包括未依法注册或备案的化妆 品；注册证被撤销的化妆品；擅自配制的化妆品；使用禁用原料生产的化妆品；药品监管部门通告停止 经营或者暂停经营的化妆品等。 同时设定11项广告内容限制条款，涵盖虚假宣传、暗示疾病预防、治疗功能等违法违规情形。特别强调 普通化妆品不得宣称特殊功效（如祛斑美白、防脱发等）。牙膏未按照国家标准、行业标准进行功效评 价，不得宣传防龋、抑牙菌斑等功能，从内容源头遏制概念炒作。 坚决杜绝低俗媚俗、制造"容貌焦虑"等内容；制定17项"负面清单"；强化儿童群体保护……近日，北京 市市场监管局、市药监局联合发布《北京市化妆品广告发布指引》（以下简称《指引》）。《指引》全 面梳理现行化妆品和广告领域相关 ...

Core Viewpoint - The establishment of the Administrative Law Enforcement Coordination and Supervision Bureau in Linyi City aims to enhance the coordination and supervision of administrative law enforcement, ensuring it is more strict, standardized, fair, and civilized [1][3]. Group 1: Administrative Law Enforcement System - Linyi City has focused on improving the quality of administrative law enforcement and standardizing enterprise-related law enforcement, completing a pilot for a four-level administrative law enforcement coordination and supervision system [2]. - The city has established "Administrative Law Enforcement Coordination and Supervision Offices" in all 156 town (street) judicial offices, detailing 99 responsibilities across city, county, and township levels [2]. - A new regulatory framework has been introduced, including the "Linyi City Enterprise Classification and Regulation Method (Trial)," which aims to create a classification standard system for enterprise regulation based on industry characteristics [2]. Group 2: Supervision and Inspection Mechanisms - Five major systems have been established to manage enterprise-related administrative inspections, ensuring that checks are only conducted according to set standards and plans [2]. - The government and discipline inspection commission have created a "dual special team" mechanism to address prominent issues in administrative law enforcement, resulting in the rectification of over 1,800 problems over four years [2]. - The "Joint Inspection Platform for Enterprises" has been developed, leading to a 35% year-on-year decrease in average monthly enterprise inspections in 2024 [2]. Group 3: Future Directions - The Linyi City Judicial Bureau plans to leverage the establishment of the new bureau to enhance its responsibilities and continue promoting strict, standardized, fair, and civilized law enforcement, providing strong legal support for high-quality economic and social development in the city [3].

Group 1 - The State Administration for Market Regulation has approved the release of 43 national metrology technical standards, including 29 newly formulated and 14 updated standards [1] - The new standards cover various fields such as digital transformation, healthcare, livelihood security, and ecological environment [1]

九江市审计局制定 《审计项目进度管理办法（试行）》 为强化审计项目进度管控，提高审计工作效率，根据深入开展"科学规范提升年"行动部署要求，近日，九江市审计局制定了《审计项目进度管理办法（试 行）》（以下简称《办法》）。《办法》共分为五章，二十二条，对审计项目全流程各阶段的完成时限、责任单位和责任落实等方面作出明确规定。 一是划分项目类型，科学核定时限。《办法》按照统一管理、分级负责、公平适度、注重效能的原则，实行分类把控。按照项目类型、项目资金规模、审 计事项复杂程度和审计组织方式等因素，科学确定现场实施、征求意见、复核审理、出具报告等阶段时限，做到审计项目相关工作均衡推进。 二是注重过程控制，规范进度管理。《办法》严格限时管理，以审计组进点之日为起始，到审计报告正式签发之日为止，将审计项目分为现场实施、征求 意见、复核审理和出具报告4个阶段，分别确定每个阶段的完成时限，实行审计全流程进度控制。 创新"全周期"质量管控体系，建立审前调查清单、现场管理清单等5类清单制度，制定《审计项目全流程责任图》《法规审理流程图》等标准化模板，编 制了审计项目全流程风险节点控制图等12份导图，条目式列示审计全流程各环节风险节 ...

Core Insights - The emerging profession of medical companions is addressing the increasing difficulty elderly individuals face in accessing healthcare services, particularly in Shanghai where the number of certified companions has surpassed one thousand [1] - The professionalization of medical companions is hindered by a lack of regulatory standards and recognition within the national occupational classification system, leading to issues such as identity ambiguity and market disruption by unscrupulous entities [1] - The current pricing model for companion services is primarily low-cost due to the weak willingness of elderly individuals to spend, which poses challenges for establishing a sustainable business model [1] Short-term and Long-term Solutions - Short-term efforts should focus on promoting national occupational certification for medical companions and establishing nationwide service standards [2] - Long-term strategies should include talent development through specialized training programs, enhancing job security with dedicated insurance products, and expanding the companion service industry by integrating it with related services like rehabilitation equipment rental and home care [2] - The normalization of the medical companion industry is crucial, with government support to include these services in basic elderly care offerings and companies leveraging technology to improve efficiency and service quality [2]

Core Viewpoint - The company successfully passed the FDA's cGMP inspection, which is a significant achievement that enhances its competitiveness and supports its expansion into the U.S. raw material drug market [1][2]. Group 1: FDA Inspection Details - The company underwent an FDA cGMP inspection from February 12 to February 17, 2025, focusing on the production of nine active pharmaceutical ingredients [1]. - The inspection covered various systems including quality, production, equipment, laboratory control, and material management [1]. - The company received the Establishment Inspection Report (EIR) confirming the successful completion of the inspection [1]. Group 2: Implications for the Company - Passing the FDA inspection establishes a solid foundation for the company's further expansion into the U.S. raw material drug market [2]. - This achievement is expected to inject momentum into the company's ongoing international market expansion efforts [2]. - The successful inspection is anticipated to enhance the company's overall competitiveness and promote future development [2].

Group 1 - The purpose of the rules is to standardize the decision-making process of the board of directors of Dazhong Mining Co., Ltd. and enhance its operational efficiency [1] - The board consists of 7 directors, including 3 independent directors and 1 employee representative [3] - The chairman and vice-chairman of the board are elected by a majority of the directors [3] Group 2 - The board has the authority to convene shareholder meetings and report on its work [2] - It is responsible for executing shareholder resolutions and determining the company's operational plans and investment proposals [2] - The board must explain any non-standard audit opinions issued by the registered accountant to the shareholders [3] Group 3 - The board must establish strict review and decision-making procedures for external investments, asset acquisitions, and other significant transactions [3] - Major transactions must be approved by the board and disclosed in a timely manner [4] - Specific thresholds for board approval of transactions are set, including asset total exceeding 10% of the latest audited total assets [4][5] Group 4 - The board must hold at least two regular meetings annually, with the chairman responsible for convening them [6] - Special meetings can be called under certain conditions, such as proposals from shareholders holding more than 10% of voting rights [7] - Meeting notifications must be sent out at least 10 days in advance for regular meetings [8] Group 5 - A quorum for board meetings requires the presence of more than half of the directors [18] - Decisions must be made by a majority vote of the directors present [18] - Directors can delegate their voting rights to other directors, but independent directors cannot delegate to non-independent directors [19] Group 6 - Meeting records must include details such as the date, attendees, agenda, and voting results [33] - The board's resolutions must be announced in accordance with legal requirements [37] - The board chair and vice-chair are responsible for ensuring the implementation of board resolutions [38]

公司董事会应当切实履行职责，认真、按时组织股东会。公司全体董事应当 勤勉尽责，确保股东会正常召开和依法行使职权。 第三条 股东会应当在《公司法》和《公司章程》规定的范围内行使职权。 下列事项应当经股东会审议通过： 一、 公司发生的以下交易（提供担保、提供财务资助除外）应提交股东会 审议： 南京海辰药业股份有限公司 股东会议事规则 第一章 总 则 第一条 为规范公司行为，保证股东会依法行使职权，根据《中华人民共和 国公司法》（以下简称《公司法》）、《中华人民共和国证券法》（以下简称《证券 法》）等法律、法规及《公司章程》，制定本规则。 第二条 公司应当严格按照法律、行政法规、本规则及《公司章程》的相关 规定召开股东会，保证股东能够依法行使权利。 (一) 交易涉及的资产总额占公司最近一期经审计总资产的 50%以上，该交 易涉及的资产总额同时存在账面值和评估值的，以较高者作为计算依据； (二) 交易标的（如股权）在最近一个会计年度相关的营业收入占公司最近 一个会计年度经审计营业收入的 50%以上，且绝对金额超过 5,000 万元； (三) 交易标的（如股权）在最近一个会计年度相关的净利润占公司最近一 个会计年度经审 ...

《深圳证券交易所股票上市规则》、 《深圳证券交易所上市公司自律监 管指引第 1 号——主板上市公司规范运作》和《亚世光电（集团）股份有限公司 章程》 亚世光电（集团）股份有限公司 第一章 总则 第一条 为了规范亚世光电（集团）股份有限公司(以下简称"公司")与控 股股东、实际控制人及其他关联方的资金往来，最大程度保护投资者合法权益， 避免控股股东、实际控制人及其他关联方资金占用行为的发生，根据《中华人民 《上市公司监管指引第 8 号——上市公司资金往来、对外担保的 共和国公司法》、 监管要求》、 （以下简称"《公司章程》"）以及其他法律、法规及规范性文件的有关规定， 制定本制度。 第二条 公司及纳入公司合并会计报表范围的子公司与控股股东、实际控制 人及其他关联方之间资金往来适用本制度。 除本条规定外，本制度所称的公司均指公司及纳入公司合并会计报表范围的 子公司。 第三条 本制度所称资金占用包括但不限于：经营性资金占用和非经营性资 金占用。经营性资金占用是指控股股东、实际控制人及其他关联方通过采购、销 售等生产经营环节的关联交易产生的资金占用；非经营性资金占用是指公司为控 股股东、实际控制人及其他关联方垫支工资 ...

Core Viewpoint - Food safety is crucial for public welfare and development, with recent data indicating a stable improvement in food safety in China, highlighted by high compliance rates in food safety inspections and a significant decrease in consumer complaints [1][2][39]. Group 1: Food Safety Inspection Data - From 2021 to 2023, the national food safety inspection sample pass rate remained above 97%, with specific categories like grains, oils, meats, eggs, and dairy achieving over 99% compliance in 2023 [1][3][6]. - In 2024, the food safety evaluation inspection pass rate reached 99.2%, with a notable increase in the number of food categories passing inspections [1][6][17]. - The five major food categories (grains, oils, meats, eggs, dairy) all exceeded a 99% pass rate for the first time since 2019 [3][6]. Group 2: Main Risks and Issues - The primary risks identified in food safety inspections include pesticide residue exceeding limits, microbial contamination, and the misuse of food additives, with pesticide residue issues increasing from 26.38% in 2021 to 37.66% in 2023 [7][10][15]. - The misuse of food additives has become a significant concern, particularly in 2024, where it was identified as the leading cause of non-compliance [1][17][20]. Group 3: Regulatory Developments - The Chinese government has strengthened food safety regulations, including a comprehensive approach from farm to table, as outlined in recent policy documents [2][39]. - The implementation of new national standards for food additives in February 2025 aims to address the misuse of additives and improve overall food safety [35][36]. Group 4: Consumer Protection and Complaints - Consumer complaints regarding food safety have seen a significant decline, with a reported decrease of 18.6 percentage points in complaint growth compared to the previous year [39]. - The government has taken steps to enhance consumer rights and transparency in food safety, leading to a higher rate of resolved disputes and improved consumer confidence [39].